Target intelligence / Profile preview

DDB1- and CUL4-associated factor 10 (DCAF10)

Target
DCAF10
Molecular classification
WD repeat domain containing protein, substrate receptor for E3 ubiquitin ligase complex
01

Overview

DDB1- and CUL4-associated factor 10 (DCAF10) is a WD repeat domain-containing protein that acts as a substrate receptor within the CUL4–DDB1 E3 ubiquitin ligase complex[1][3]. It is involved in targeting proteins for ubiquitination, a post-translational modification that leads to protein degradation via the ubiquitin–proteasome system[1][3]. DCAF10 plays a regulatory role in apoptosis, particularly by promoting the degradation of antiapoptotic proteins such as MCL1, thus activating caspase-dependent cell death pathways[1]. Downregulation or loss of DCAF10 has been observed in certain cancers, such as lung adenocarcinomas, suggesting its function in tumor suppression or oncogenesis[1]. It is also genetically associated with diseases like limb-girdle muscular dystrophy and corpus luteum cysts[3]. At present, DCAF10 is not considered a direct therapeutic target, and no drugs or biomarkers are reported to interact directly with it.

Other names
WDR32WD repeat-containing protein 32WD repeat domain 32MGC10765FLJ23201
02

Biological functions

Protein ubiquitinationRegulation of protein degradation (via ubiquitin–proteasome system)Apoptosis (regulation through targeted proteolysis)
03

Disease associations

Cancer (notably, loss in lung adenocarcinoma)Limb-girdle muscular dystrophyCorpus luteum cyst

Beyond the preview

Go deeper on DDB1- and CUL4-associated factor 10 (DCAF10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDB1- and CUL4-associated factor 10 (DCAF10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call